Clinical trial · no report yet · Phase 3
NCT05863195
Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial
- NCT05863195 ↗
- Recruiting
- ECOG-ACRIN Cancer Research Group
- 38 commentary sources found
- Standard
We haven't built a report for this trial yet. This page shows the registry record and the public commentary we found that names the trial. A report reads that commentary and sets out what clinicians said about the trial, each point linked to its source. How reports are made.
Commentary we found
Podcasts, YouTube videos and X posts in our index that name this trial. A report screens them, searches for more and cites what clinicians said when it is built.
| Channel | Found | |
|---|---|---|
| X threads | 33 | |
| Podcasts | 4 | |
| YouTube | 1 |
The trial
ClinicalTrials.gov- Official title
- A Randomized Phase III Study of Systemic Therapy With or Without Hepatic Arterial Infusion for Unresectable Colorectal Liver Metastases: The PUMP Trial
- Phase
- Phase 3
- Status
- Recruiting
- Conditions
- Metastatic Colorectal Carcinoma; Metastatic Malignant Neoplasm in the Liver; Stage IV Colorectal Cancer AJCC v8; Unresectable Colorectal Carcinoma
- Interventions
- Bevacizumab; Capecitabine; Cetuximab; Computed Tomography; Floxuridine; Fluorouracil; Implantation; Intrahepatic Infusion Procedure; Irinotecan; Leucovorin; Magnetic Resonance Imaging; Oxaliplatin; Panitumumab; Single Photon Emission Computed Tomography
- Arms
- Arm A (HAI, floxuridine, standard chemotherapy) · Experimental
- Arm B (standard chemotherapy) · Active comparator
- Enrollment
- 408 (estimated)
- Primary outcomes
- Overall survival (OS)
- Sponsor
- ECOG-ACRIN Cancer Research Group
- Start
- Apr 10, 2024
- Primary completion
- Jun 30, 2029 (estimated)
- Results posted
- No
- Registry record
- NCT05863195 · updated Sep 24, 2026